These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31943318)

  • 1. A qualitative study of clinician attitudes towards closed-loop systems in mainstream diabetes care in England.
    Farrington C; Murphy HR; Hovorka R
    Diabet Med; 2020 Jun; 37(6):1023-1029. PubMed ID: 31943318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England.
    Farrington C; Hovorka R; Murphy HR
    Diabetes Technol Ther; 2020 May; 22(5):404-410. PubMed ID: 31913061
    [No Abstract]   [Full Text] [Related]  

  • 3. Health professionals' views about who would benefit from using a closed-loop system: a qualitative study.
    Lawton J; Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Randell T; Besser REJ; Trevelyan N; Hovorka R;
    Diabet Med; 2020 Jun; 37(6):1030-1037. PubMed ID: 31989684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial.
    Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Ghatak A; Randell T; Besser REJ; Trevelyan N; Hovorka R; Lawton J
    Diabetes Technol Ther; 2020 Jun; 22(6):468-475. PubMed ID: 32048877
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.
    Farrington C
    Diabet Med; 2018 Apr; 35(4):436-449. PubMed ID: 29247547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do-it-yourself closed-loop systems for people living with type 1 diabetes.
    Dowling L; Wilmot EG; Choudhary P
    Diabet Med; 2020 Dec; 37(12):1977-1980. PubMed ID: 32420640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.
    Lawton J; Blackburn M; Rankin D; Allen JM; Campbell FM; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Elleri D; Hovorka R
    Diabetes Technol Ther; 2019 Mar; 21(3):119-127. PubMed ID: 30720338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes: Healthcare Professionals' Views About Potential Challenges and Solutions.
    Rankin D; Hart RI; Kimbell B; Barnard-Kelly K; Brackenridge A; Byrne C; Collett C; Dover AR; Hartnell S; Hunt KF; Lee TTM; Lindsay RS; McCance DR; McKelvey A; Rayman G; Reynolds RM; Scott EM; White SL; Hovorka R; Murphy HR; Lawton J
    Diabetes Technol Ther; 2023 Apr; 25(4):260-269. PubMed ID: 36662589
    [No Abstract]   [Full Text] [Related]  

  • 9. Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes.
    Hng TM; Burren D
    Intern Med J; 2018 Nov; 48(11):1400-1404. PubMed ID: 30387315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Go Ahead, Pick Your Pump.
    Scheiner G
    Diabetes Forecast; 2016; 69(2):68-75. PubMed ID: 27048051
    [No Abstract]   [Full Text] [Related]  

  • 12. Women's Experiences of Day-and-Night Closed-Loop Insulin Delivery During Type 1 Diabetes Pregnancy.
    Farrington C; Stewart Z; Hovorka R; Murphy H
    J Diabetes Sci Technol; 2018 Nov; 12(6):1125-1131. PubMed ID: 30288999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining the closed loop in the data age: research-to-practice transitions in diabetes technology.
    Forlenza GP; Sankaranarayanan S; Maahs DM
    Diabetes Technol Ther; 2015 May; 17(5):304-6. PubMed ID: 25844981
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous glucose monitoring and closed-loop systems.
    Hovorka R
    Diabet Med; 2006 Jan; 23(1):1-12. PubMed ID: 16409558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.
    Rodbard D
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S3-S13. PubMed ID: 26784127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Matters Most. People weigh in on why they use their diabetes management products.
    Wahowiak L
    Diabetes Forecast; 2016; 69(2):46-9. PubMed ID: 27048048
    [No Abstract]   [Full Text] [Related]  

  • 18. Technology to Reduce Hypoglycemia.
    Yeoh E; Choudhary P
    J Diabetes Sci Technol; 2015 Jul; 9(4):911-6. PubMed ID: 25883167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges for outpatient closed loop studies: how to assess efficacy.
    Beck RW; Calhoun P; Kollman C
    Diabetes Technol Ther; 2013 Jan; 15(1):1-3. PubMed ID: 23297669
    [No Abstract]   [Full Text] [Related]  

  • 20. More Consumer Diabetes Products Using Technology to Get--and Stay--Connected.
    Dubois W
    Diabetes Self Manag; 2016; 33(2):36-8, 40, 42. PubMed ID: 27086399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.